| PRIMARY INFORMATION |
|---|
| ID | 1623 |
| PMID | 2118954 |
| Year | 1989 |
| Sequence | Y(SO3H)MGWMT(SO3H)(NCH3)F |
| Name | Cholecystokin |
| Length | 6 |
| N-Terminal Modification | Free |
| C-Terminal Modification | Acetylation |
| Linear/ Cyclic | Linear |
| Chirality | L |
| Chemical Modification | None |
| Origin of Peptide | Synthetic |
| Nature of Peptide/Cargo | Not mentioned |
| Mechanism | Not mentioned |
| Cargo Sequence/Structure | No cargo |
Name of cargo
| Not applicable |
| Assay | HPLC |
| Enhancer | Pretreatment of skin with ethanol. |
| Properties of enhancer | Not mentioned |
| Concentration | 0.5 ml |
| Incubation time | 12-24 hrs |
| Tissue permeability (value with units) | An applied voltage of 0.25 V across the skin produced an enhancement of -4-fold in the flux of the CCK-8 analogue over passive permeation alone after pretreatment of skin with ethanol. |
| Tissue Sample | human skin from tummy-tuck surgery (when available) or frozen skin from skin banks |
| Ex vivo/In vivo/In vitro | in vitro |
| SECONDARY INFORMATION |
|---|
| STRUCTURE | |
| SMILES | N.A. |
